Open AccessA meta-analysis of efficacy and safety of sorafenib versus other targeted agents for metastatic renal cell carcinoma
Author(s) -
Haitao Wang,
Ming Xia
Publication year - 2019
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000013779
Subject(s) - sorafenib , medicine , renal cell carcinoma , meta analysis , oncology , adverse effect , confidence interval , cochrane library , odds ratio , clinical endpoint , clinical trial , hepatocellular carcinoma